An international team of UK and US scientists discovered that the activity of macrophages -- a type of white blood cell that engulf pathogens and cancer cells -- can be used to predict whether or not ...

Incorporating genomic testing into the management of cervical cancer allows for the creation of personalized treatment plans ...

The melding of visual information (microscopic and X-ray images, CT and MRI scans, for example) with text (exam notes, communications between ...

An international team of UK and US scientists has discovered that the activity of macrophages—a type of white blood cell that ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Top-line Phase 2/3 data readout for CTX-009, now named tovecimig (a DLL4 x VEGF-A bispecific), in patients with biliary tract cancer (BTC) is on ...

Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer deaths worldwide. In 2023, ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it will participate in and present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, ...

Biologic drug is a product that contain components of living organisms such as animal, human, or produced from living organisms. Mr. Shah Coherent Market Insights Pvt. Ltd. +1 2524771362 email us here ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...